CHAMP: A Phase II Study of Panitumumab With Pemetrexed and Cisplatin Versus Pemetrexed and Cisplatin in the Treatment of Patients With Advanced-Stage Primary Nonsquamous Non-Small-Cell Lung Cancer With Particular Regard to the KRAS Status
Erstveröffentlichung
2015
Wissenschaftlicher Artikel
Published in
Clinical Lung Cancer ; 16 (2015), 6. - S. 447-456. - ISSN 1525-7304. - eISSN 1938-0690
Link to publication
https://dx.doi.org/10.1016/j.cllc.2015.05.009Institutions
UKU. Klinik für Innere Medizin IIKlinikum Kempten Oberallgäu gGmbH
Subject headings
[Free subject headings]: Epidermal growth factor receptor | KRAS | Non-small cell lung cancer | Panitumumab | Pemetrexed/cisplatin | COOPERATIVE-ONCOLOGY-GROUP | CLINICAL-TRIALS | SOLID TUMORS | CHEMOTHERAPY | BIOMARKERS | CETUXIMAB | FLEX[DDC subject group]: DDC 610 / Medicine & health